| COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease R Sheervalilou, M Shirvaliloo, N Dadashzadeh, S Shirvalilou, O Shahraki, ... Journal of Cellular Physiology 235 (12), 8873-8924, 2020 | 81 | 2020 |
| Viral coinfections in COVID‐19 PS Aghbash, N Eslami, M Shirvaliloo, HB Baghi Journal of Medical Virology 93 (9), 5310-5322, 2021 | 69 | 2021 |
| Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review S Shirvalilou, S Khoei, AJ Esfahani, M Kamali, M Shirvaliloo, ... Journal of Neuro-Oncology 152, 419-428, 2021 | 43 | 2021 |
| The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets S Sargazi, R Sheervalilou, M Rokni, M Shirvaliloo, O Shahraki, N Rezaei Cell biology international, 2021 | 40 | 2021 |
| The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment RM Heris, M Shirvaliloo, S Abbaspour-Aghdam, A Hazrati, A Shariati, ... Stem Cell Research & Therapy 13 (1), 371, 2022 | 38 | 2022 |
| Electrochemical nano-biosensors as novel approach for the detection of lung cancer-related MicroRNAs R Sheervalilou, O Shahraki, L Hasanifard, M Shirvaliloo, S Mehranfar, ... Current molecular medicine 20 (1), 13-35, 2020 | 36 | 2020 |
| Recent advances in iron oxide nanoparticles for brain cancer theranostics: from in vitro to clinical applications R Sheervalilou, M Shirvaliloo, S Sargazi, H Ghaznavi Expert Opinion on Drug Delivery, 2021 | 29 | 2021 |
| Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer M Razlansari, S Jafarinejad, A Rahdar, M Shirvaliloo, R Arshad, ... Molecular and Cellular Biochemistry 478 (7), 1573-1598, 2023 | 28 | 2023 |
| Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients B Hashemi, FA Akram, H Amirazad, M Dadashpour, M Sheervalilou, ... Journal of drug delivery science and technology 67, 102967, 2022 | 26 | 2022 |
| Circulating MiR-10b, MiR-1 and MiR-30a Expression Profiles in Lung Cancer: Possible Correlation with Clinico-pathologic Characteristics and Lung Cancer Detection R Sheervalilou, H Lotfi, M Shirvaliloo, A Sharifi, M Nazemiyeh, ... International Journal of Molecular and Cellular Medicine (IJMCM) 8 (2), 118-129, 2019 | 26 | 2019 |
| Application of nanoparticles in cancer therapy with an emphasis on cell cycle HG Almanghadim, Z Nourollahzadeh, NS Khademi, MD Tezerjani, ... Cell biology international 45 (10), 1989-1998, 2021 | 25 | 2021 |
| Application of nanobiotechnology for early diagnosis of SARS-CoV-2 infection in the COVID-19 pandemic R Sheervalilou, M Shirvaliloo, S Sargazi, S Shirvalilou, O Shahraki, ... Applied Microbiology and Biotechnology 105, 2615-2624, 2021 | 25 | 2021 |
| Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection M Shirvaliloo Epigenomics 13 (10), 745-750, 2021 | 19 | 2021 |
| Polymorphism in the 3′-UTR of LIF but Not in the ATF6B Gene Associates with Schizophrenia Susceptibility: a Case-Control Study and In Silico Analyses M Moudi, S Sargazi, M Heidari Nia, R Saravani, M Shirvaliloo, M Shakiba Journal of Molecular Neuroscience 70, 2093-2101, 2020 | 16 | 2020 |
| SARS‐CoV‐2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective H Ghaznavi, M Shirvaliloo, S Sargazi, Z Mohammadghasemipour, ... Cell Biology International 46 (7), 1009-1020, 2022 | 14 | 2022 |
| The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks M Shirvaliloo Epigenomics 14 (3), 153-162, 2022 | 14 | 2022 |
| An updated review on implications of autophagy and apoptosis in tumorigenesis: possible alterations in autophagy through engineered nanomaterials and their importance in cancer … H Ghaznavi, M Shirvaliloo, A Zarebkohan, Z Shams, F Radnia, ... Molecular pharmacology 100 (2), 119-143, 2021 | 14 | 2021 |
| New insights into the importance of long non-coding RNAs in lung cancer: future clinical approaches H Ghahramani Almanghadim, S Ghorbian, NS Khademi, ... DNA and Cell Biology 40 (12), 1476-1494, 2021 | 13 | 2021 |
| Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer J Ebadfardzadeh, M Kazemi, A Aghazadeh, M Rezaei, M Shirvaliloo, ... Medical Oncology 38 (9), 114, 2021 | 12 | 2021 |
| Convalescent blood: current perspective on the efficacy of a legacy approach in COVID-19 treatment R Sheervalilou, M Shirvaliloo, S Sargazi, S Bahari, R Saravani, ... Blood Purification 51 (1), 1-14, 2022 | 11 | 2022 |
Roghayeh SheervalilouZahedan University of Medical Sciencestbzmed.ac.ir üzerinde doğrulanmış e-posta adresine sahip
